High-concentration protein formulations: How high is high?

Garidel, P; Kuhn, AB; Schafer, LV; Karow-Zwick, AR; Blech, M

Garidel, P (reprint author), Boehringer Ingelheim Pharma GmbH & Co KG, Proc Sci, Prot Sci, D-88397 Biberach, Germany.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017; 119 ( ): 353

Abstract

High-concentration protein formulation (HCPF) is a term that is used to describe protein formulations, mostly monoclonal antibody (mAb) drugs, at high......

Full Text Link